To further confirm this result, the Oncomine database was used to assess the expression profile of FOXA1. Elevated mRNA levels of FOXA1 were identified in various human tumors, including bladder cancer, breast cancer, esophageal cancer, lung cancer, and prostate cancer (Figure 3A). This evidence concerns the gene FOXA1 and prostate carcinoma.